RSV vaccine candidate encapsulated in a lipid nanoparticle formulation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RSV vaccine candidate encapsulated in a lipid nanoparticle formulation, covering 2026-08-05 to 2026-08-05. Get the full timeline:
Most recent: Clinical Trial Results: Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and Older [Phase 1, Phase 2]